KURE ETF (KraneShares MSCI All China Health Care Index ETF) is managed by KraneShares with $77.4M in net assets. KURE expense ratio is 0.65%, holding 54 positions across sectors including Unknown, Health Care, Information Technology. Inception date: 2018-01-31.

KURE performance shows a YTD return of -1.03%. The 1-year return is -3.15% and the 5-year return is -16.02%. KURE dividend yield stands at 4.50%, paid annually.

KURE top holdings include Innovent Biologics Inc (9.2%), Beigene Ag (8.5%), Wuxi Biologics Cayman Inc (6.7%), Wuxi Apptec Co. Ltd. Class A (6.1%), Shenzhen Mindray Bio-Medical Electronics Co Ltd (4.5%). View all KURE holdings, sector breakdown, or dividend history.

KURE can be compared against other funds using the overlap calculator or side-by-side comparison tool. KURE alternatives are available via the screener, along with tax-loss harvesting opportunities.